Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 1354
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size
 
ORIGINAL ARTICLE
Ahead of Print

The immunohistochemical Galectin-3 expression in tumor and cancer-associated fibroblasts in invasive ductal carcinomas of breast and their relationship with clinicopathological parameters


1 Department of Pathology, Istanbul Training and Research Hospital, University of Health Science, Istanbul, Turkey
2 Department of General Surgery, Istanbul Training and Research Hospital, University of Health Science, Istanbul, Turkey
3 Department of Radiation Oncology, Istanbul Training and Research Hospital, University of Health Science, Istanbul, Turkey

Correspondence Address:
Yasemin Cakir,
Istanbul Training and Research Hospital, University of Health Sciences, Department of Pathology, Kasap Ilyas District, Orgeneral Abdurrahman Nafiz Gurman Street, Fatih, Istanbul, 34098
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijpm.ijpm_284_21

Background: Galectin-3 has an important role in metastasis, therefore, Galectin-3-focused therapies have attracted attention for various cancers. Aim: We aimed to reveal the relationship between the expression of Galectin-3 within the tumor/cancer-associated fibroblasts (CAF) and clinicopathological parameters in patients with invasive ductal carcinomas. Material and Methods: Hematoxylin and eosin-stained slides of breast excision materials diagnosed between 2010 and 2016 were re-examined retrospectively. Accordingly, 118 cases (luminal group = 58, Human epidermal growth factor receptor 2 (HER2) group = 27, and triple-negative breast carcinoma group [TNBC] =33 cases) were included. Galectin-3 levels were evaluated with a calculated H-score in tumor and semiquantitatively in CAFs. Statistical Analysis: Data was analyzed with t-tests and Chi-square tests. Kaplan–Meier and Log-rank tests were used for survival analysis. Results: The presence of Galectin-3 expression in CAFs but not in the tumor was associated with the greater number of axillary metastatic nodes and advanced pN stage. The loss of Galectin-3 expression in CAFs was more frequent in TNBC. There was no significant relationship between the expression level of Galectin-3 and survival status. However, in most of the cases with distant metastasis or patients who died, Galectin-3 was negative in the tumor, whereas it was positive in CAFs. Conclusions: The expression of Galectin-3 in tumors and CAFs may have a role in metastasis to axillary lymph nodes and distant sites. In terms of molecular subtype, TNBCs show a relationship with Galectin-3 negativity in CAFs.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Cakir Y
    -  Talu CK
    -  Trabulus DC
    -  Mermut O
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed591    
    PDF Downloaded34    

Recommend this journal